InsiderTrades

Form 4 for TELA TELA Bio, Inc.

Accepted 2025-02-25 00:00:00 ET · period of report 2025-02-21 · accession 0001062993-25-003499 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-02-25 2025-02-23 TELA Cuca Roberto COO, CFO F - Tax $2.72 -5,234 208.2K -2% -$14.2K
D 2025-02-25 2025-02-21 TELA Cuca Roberto COO, CFO A - Grant $0.00 +57.0K 213.5K +36% $0
D 2025-02-25 2025-02-21 TELA Cuca Roberto COO, CFO A - Grant $0.00 +83.8K 83.8K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-02-23 F D 5,234 $2.72 208,233 D — — (F3) Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs.
2 Common Common Stock 2025-02-21 A A 57,000 $0.00 213,467 D — — (F1) These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 21, 2026, subject to the Reporting Person's continuous service through the applicable vesting dates. (F2) Includes 1,079 shares acquired under the Company's employee stock purchase plan on January 31, 2025.
3 Derivative Stock Option (Right to Buy) 2025-02-21 A A 83,800 $0.00 83,800 D $2.72 · — to 2035-02-21 83,800 Common Stock (F4) The option vests 25% on February 21, 2026, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.